semaglutide gastrointestinal obstruction class action in dallas a randomized trial of over 1400 participants with BMI ≥30 kg/m2, those assigned to weekly subcutaneous 7.2 mg lost about 3 percent more of their body weight after 72 weeks Thousands of lawsuits are being

These effects were often more noticeable when doses were increased

Judicial Panel on Multidistrict Litigation (JPML) is expected to hold a hearing in January 2024 to determine whether to consolidate all Ozempic stomach paralysis lawsuits before one judge for discovery and pretrial proceedings

Compounded GLP-1s are not FDA-approved products

If nausea persists beyond the first 48 hours after injection, your PlexusDx provider may adjust your dose or recommend anti-nausea strategies

If your diarrhea episodes are consistently preceded by significant bloating, the root cause is likely the delayed gastric emptying rather than a direct intestinal irritation

None of these were symptomatic